American Heart Association Atrial Fibrillation Research Summit A Conference Report From the American Heart Association
American Heart Association Atrial Fibrillation Research Summit A Conference Report From the American Heart Association
复制标题
DOI：
10.1161/cir.0b013e318224b037
复制
发表时间：
2011-07-19
期刊：
影响因子：
37.8
通讯作者：
Benjamin, Emelia J.
中科院分区：
文献类型：
--
作者：
Estes, N. A. Mark, III;Sacco, Ralph L.;Benjamin, Emelia J.
房颤(AF)是全球公共卫生面临的重大挑战，因为它的患病率正在增加，并与中风、痴呆症、心力衰竭和死亡的风险增加有关。1-3为了应对房颤带来的诸多挑战，美国心脏协会(AHA)于2010年6月12日至13日在华盛顿特区召开了一次会议，与会者包括患者、护士、医生以及医疗保健政策制定者和监管机构。此外，基础科学家、转化科学家、人口科学家、结果科学家和临床科学家也参与了研究(附录)。22个演讲和6个小组讨论被组织成4个会议：(1)房颤的机制：基础和转化科学和遗传学；(2)流行病学、结果、成本、房颤和卒中预防；(3)迎接房颤的临床挑战；以及(4)重新定义房颤的治疗目标(附录)。本报告的重点是概述首脑会议与会者提出的关键概念和提出的核心建议。
Atrial fibrillation (AF) poses a major global public health challenge because it is increasing in prevalence and is associated with an increased risk of stroke, dementia, heart failure, and death. 1–3 In response to the many challenges posed by AF, the American Heart Association (AHA) convened a conference in Washington, DC, on June 12–13, 2010, that included patients, nurses, physicians, and healthcare policy makers and regulators. In addition, basic, translational, population, outcomes, and clinical scientists participated (Appendix). The 22 presentations and 6 panel discussions were organized into 4 sessions:(1) Mechanisms of AF: Basic and Translational Science and Genetics;(2) Epidemiology, Outcomes, Cost, AF, and Stroke Prevention;(3) Meeting the Clinical Challenges in AF; and (4) Redefining the Therapeutic Goals of AF (Appendix). The focus of the present report is to provide an overview of the key concepts presented and the core recommendations made by the summit participants.